Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Sep 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$852K
Net Open-Market Flow
-$852K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 5, 2025Sell(S)3K$33.22$103K0
Sep 5, 2025Option exercise(M)27K$0.60$16K27K
Sep 5, 2025Sell(S)7K$32.64$244K3K
Sep 5, 2025Sell(S)4K$31.42$129K11K
Sep 5, 2025Sell(S)12K$30.47$376K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 5, 2025Option exercise(M)27K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-113556) within minutes of acceptance. Every field above traces to the original document. Verify it directly: